Virus-Serum-Toxin Act and Regulations in 9 CFR Subchapter, Parts 101-124
Revision of a currently approved collection
No
Regular
02/23/2022
Requested
Previously Approved
36 Months From Approved
02/28/2022
435,797,533
298,820,801
43,072
122,998
0
0
The purpose of this collection is to verify that compliance requirements for biological products used in the United States are met (i.e., the products are pure, safe, potent, and effective).
APHIS Form 2080, APHIS Form 2018, APHIS Form 2003, APHIS Form 2005, APHIS Form 2008, APHIS Form 2008A, APHIS Form 2047S, APHIS Form 2048, APHIS Form 2046, APHIS Form 2047, APHIS Form 2049, APHIS Form 2046S, APHIS Form 2070, APHIS Form 2071, APHIS Form 2001, APHIS Form 2007, APHIS Form 2020, APHIS Form 2072, APHIS Form 2009, APHIS Form 2015, APHIS Form 2017
This request for renewal reflects an increase of 136,976,732 responses and a decrease of 79,926 hours of burden, largely attributable to significant increases in package labeling, adjustments to several activities previously overestimated, adjustments to response times, and the discontinuance of three activities that are no longer used.
$2,606,101
No
No
No
No
No
No
No
Bonnie Coyle 515 337-6561
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Form APHIS Form 2001 Business
0013 2022 SS.docx
0013 2022 APHIS 79.xlsx
Foreign Gov't